Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD- S. Typhi-specific IgA and IgG B memory cells in humans

Clinical Immunology

Volumn 138, Issue 2, 2011, Pages 187-200

  Wahid, Rezwanul ^a   Pasetti, Marcela F ^a   Maciel, Milton ^a   Simon, Jakub K ^a   Tacket, Carol O ^a   Levine, Myron M ^a   Sztein, Marcelo B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

B memory; CVD 909; Prime boost immunization; S. Typhi; Ty21a; Vaccine; Vi capsular polysaccharide

Indexed keywords

ANTIGEN; BACTERIAL POLYSACCHARIDE; CD19 ANTIGEN; CD27 ANTIGEN; CD3 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; POLYSACCHARIDE VACCINE; TYPHIM; TYPHOID VACCINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; FLAGELLUM; HUMAN; IMMUNIZATION; IMMUNOLOGICAL MEMORY; MALE; MEMORY CELL; MUCOSA; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SALMONELLA TYPHI; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; ANTIGENS, CD27; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; POLYSACCHARIDES, BACTERIAL; SALMONELLA TYPHI; SALMONELLA VACCINES; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; YOUNG ADULT;

EID: 79251595223     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.11.006     Document Type: Article

References (52)

1. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull. World Health Organ. 2004, 82:346-353.
2. Crump J.A., Mintz E.D. Global trends in typhoid and paratyphoid fever. Clin. Infect. Dis. 2010, 50:241-246.
3. Klugman K.P., Koornhof H.J., Robbins J.B., Le Cam N.N. Immunogenicity, efficacy and serological correlate of protection of Salmonella Typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996, 14:435-438.
4. Levine M.M., Ferreccio C., Abrego P., Martin O.S., Ortiz E., Cryz S. Duration of efficacy of Ty21a, attenuated Salmonella Typhi live oral vaccine. Vaccine 1999, 17(Suppl 2):S22-S27.
5. Hessel L., Debois H., Fletcher M., Dumas R. Experience with Salmonella Typhi Vi capsular polysaccharide vaccine. Eur. J. Clin. Microbiol. Infect. Dis. 1999, 18:609-620.
6. Michel R., Garnotel E., Spiegel A., Morillon M., Saliou P., Boutin J.P. Outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast. Eur. J. Epidemiol. 2005, 20:635-642.
7. Szu S.C., Robbins J.B., Schneerson R., Lin F.Y. Polysaccharide-based conjugate vaccines for enteric bacterial infections: typhoid fever, non-typhoidal Salmonellosis, and Escherichia coli 0157:H7. New Generation Vaccines 2010, 489-496. Informa Healthcare USA, Inc., New York, NY. M.M. Levine, G. Dougan, M.F. Good, M.A. Liu, G.J. Nabel, J.P. Nataro, R. Rappuoli (Eds.).
8. Salerno-Goncalves R., Pasetti M.F., Sztein M.B. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 2002, 169:2196-2203.
9. Salerno-Goncalves R., Wahid R., Sztein M.B. Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant vβ repertoires. Infect. Immun. 2005, 73:3521-3530.
10. Salerno-Goncalves R., Fernandez-Vina M., Lewinsohn D.M., Sztein M.B. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 2004, 173:5852-5862.
11. M.B. Sztein, Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans, Clin. Infect. Dis. 45 Suppl 1:S15-9. (2007) S15-S19.
12. Guzman C.A., Borsutzky S., Griot-Wenk M., Metcalfe I.C., Pearman J., Collioud A., Favre D., Dietrich G. Vaccines against typhoid fever. Vaccine 2006, 24:3804-3811.
13. Kirkpatrick B.D., Tenney K.M., Larsson C.J., O'Neill J.P., Ventrone C., Bentley M., Upton A., Hindle Z., Fidler C., Kutzko D., Holdridge R., Lapointe C., Hamlet S., Chatfield S.N. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. J. Infect. Dis. 2005, 192:360-366.
14. Salerno-Goncalves R., Wyant T.L., Pasetti M.F., Fernandez-Vina M., Tacket C.O., Levine M.M., Sztein M.B. Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA. J. Immunol. 2003, 170:2734-2741.
15. Tacket C.O., Sztein M.B., Wasserman S.S., Losonsky G., Kotloff K.L., Wyant T.L., Nataro J.P., Edelman R., Perry J., Bedford P., Brown D., Chatfield S., Dougan G., Levine M.M. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect. Immun. 2000, 68:1196-1201.
16. Tacket C.O., Levine M.M. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression. Clin. Infect. Dis. 2007, 45(Suppl 1):S20-S23.
17. Wang J.Y., Noriega F.R., Galen J.E., Barry E., Levine M.M. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909. Infect. Immun. 2000, 68:4647-4652.
18. Tacket C.O., Pasetti M.F., Sztein M.B., Livio S., Levine M.M. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. J. Infect. Dis. 2004, 190:565-570.
19. Wahid R., Salerno-Goncalves R., Tacket C.O., Levine M.M., Sztein M.B. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. Vaccine 2007, 25:1416-1425.
20. Levine M.M., Sztein M.B. Vaccine development strategies for improving immunization: the role of modern immunology. Nat. Immunol. 2004, 5:460-464.
21. Taillardet M., Haffar G., Mondiere P., Asensio M.J., Gheit H., Burdin N., Defrance T., Genestier L. The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells. Blood 2009, 114:4432-4440.
22. Obukhanych T.V., Nussenzweig M.C. T-independent type II immune responses generate memory B cells. J. Exp. Med. 2006, 203:305-310.
23. Simon J.K., Wahid R., Maciel M., Picking W.L., Kotloff K.L., Levine M.M., Sztein M.B. Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates. Vaccine 2009, 27:565-572.
24. Harris A.M., Bhuiyan M.S., Chowdhury F., Khan A.I., Hossain A., Kendall E.A., Rahman A., LaRocque R.C., Wrammert J., Ryan E.T., Qadri F., Calderwood S.B., Harris J.B. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 2009, 77:3850-3856.
25. Sztein M.B., Wasserman S.S., Tacket C.O., Edelman R., Hone D., Lindberg A.A., Levine M.M. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella Typhi. J. Infect. Dis. 1994, 170:1508-1517.
26. Wyant T.L., Tanner M.K., Sztein M.B. Potent immunoregulatory effects of Salmonella Typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells. Infect. Immun. 1999, 67:1338-1346.
27. Crotty S., Aubert R.D., Glidewell J., Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Meth. 2004, 286:111-122.
28. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
29. Jayasekera C.R., Harris J.B., Bhuiyan S., Chowdhury F., Khan A.I., Faruque A.S., LaRocque R.C., Ryan E.T., Ahmed R., Qadri F., Calderwood S.B. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J. Infect. Dis. 2008, 198:1055-1061.
30. Agematsu K., Hokibara S., Nagumo H., Komiyama A. CD27: a memory B-cell marker. Immunol. Today 2000, 21:204-206.
31. Agematsu K., Nagumo H., Yang F.C., Nakazawa T., Fukushima K., Ito S., Sugita K., Mori T., Kobata T., Morimoto C., Komiyama A. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur. J. Immunol. 1997, 27:2073-2079.
32. Wahid R., Salerno-Goncalves R., Tacket C.O., Levine M.M., Sztein M.B. Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue-homing potential by oral attenuated CVD 909 typhoid vaccine in humans. Mucosal Immunol. 2008, 1:389-398.
33. Viret J.F., Favre D., Wegmuller B., Herzog C., Que J.U., Cryz S.J., Lang A.B. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria. Infect. Immun. 1999, 67:3680-3685.
34. Kollaritsch H., Cryz S.J., Lang A.B., Herzog C., Que J.U., Wiedermann G. Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and Salmonella Typhi TY21a live oral vaccines after primary immunization and reimmunization. Vaccine 2000, 18:3031-3039.
35. Tacket C.O., Ferreccio C., Robbins J.B., Tsai C.M., Schulz D., Cadoz M., Goudeau A., Levine M.M. Safety and immunogenicity of two Salmonella Typhi Vi capsular polysaccharide vaccines. J. Infect. Dis. 1986, 154:342-345.
36. Forrest B.D., LaBrooy J.T., Beyer L., Dearlove C.E., Shearman D.J. The human humoral immune response to Salmonella Typhi Ty21a. J. Infect. Dis. 1991, 163:336-345.
37. Sztein M.B., Tanner M., Polotsky Y., Orenstein J.M., Levine M.M. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella Typhi in humans. J. Immunol. 1995, 155:3987-3993.
38. Heyzer-Williams L.J., Heyzer-Williams M.G. Antigen-specific memory B cell development. Annu. Rev. Immunol. 2005, 23:487-513.
39. Kocks C., Rajewsky K. Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways. Annu. Rev. Immunol. 1989, 7:537-559.
40. Mond J.J., Lees A., Snapper C.M. T cell-independent antigens type 2. Annu. Rev. Immunol. 1995, 13:655-692.
41. Pollard A.J., Perrett K.P., Beverley P.C. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat. Rev. Immunol. 2009, 9:213-220.
42. Keitel W.A., Bond N.L., Zahradnik J.M., Cramton T.A., Robbins J.B. Clinical and serological responses following primary and booster immunization with Salmonella Typhi Vi capsular polysaccharide vaccines. Vaccine 1994, 12:195-199.
43. Taillardet M., Haffar G., Mondiere P., Asensio M.J., Gheit H., Burdin N., Defrance T., Genestier L. The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells. Blood 2009, 114:4432-4440.
44. Obukhanych T.V., Nussenzweig M.C. T-independent type II immune responses generate memory B cells. J. Exp. Med. 2006, 203:305-310.
45. Sundstrom P., Lundin S.B., Nilsson L.A., Quiding-Jarbrink M. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC). Eur. J. Immunol. 2008, 38:3327-3338.
46. Andreu-Ballester J.C., Perez-Griera J., Ballester F., Colomer-Rubio E., Ortiz-Tarin I., Penarroja O.C. Secretory immunoglobulin A (sIgA) deficiency in serum of patients with GALTectomy (appendectomy and tonsillectomy). Clin. Immunol. 2007, 123:289-297.
47. Pasetti M.F., Simon J.K., Sztein M.B., Levine M.M. Immunology of Gut Mucosal Vaccines. Immunol. Rev. 2011, 239:125-148.
48. Grimont P.A.D., Xavier W.Francois Antigenic Formulae of the Salmonella Serovars, World Health Organization Collaborating Centre for Reference and Research on Salmonella 2007, 9th edition.
49. Puohiniemi R., Heiskanen T., Siitonen A. Molecular epidemiology of two international sprout-borne Salmonella outbreaks. J. Clin. Microbiol. 1997, 35:2487-2491.
50. Ktari S., Arlet G., Verdet C., Jaoua S., Kachrid A., Ben R.S., Mahjoubi-Rhimi F., Hammami A. Molecular epidemiology and genetic environment of acquired bla ACC-1 in Salmonella enterica serotype Livingstone causing a large nosocomial outbreak in Tunisia. Microb. Drug Resist. 2009, 15:279-286.
51. Forrest B.D. Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet 1988, 1:81-83.
52. Klein U., Rajewsky K., Kuppers R. Human immunoglobulin (Ig)M+IgD+peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 1998, 188:1679-1689.